{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T15:24:09Z","timestamp":1774884249267,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,2,7]],"date-time":"2022-02-07T00:00:00Z","timestamp":1644192000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,2,7]],"date-time":"2022-02-07T00:00:00Z","timestamp":1644192000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"national natural science foundation of china","doi-asserted-by":"publisher","award":["81972380"],"award-info":[{"award-number":["81972380"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"national natural science foundation of china","doi-asserted-by":"publisher","award":["81772703"],"award-info":[{"award-number":["81772703"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"national key r&d program of china","doi-asserted-by":"crossref","award":["2019YFA09006001"],"award-info":[{"award-number":["2019YFA09006001"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Human Cell"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s13577-021-00661-6","type":"journal-article","created":{"date-parts":[[2022,2,7]],"date-time":"2022-02-07T10:13:27Z","timestamp":1644228807000},"page":"542-556","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["MiR-182-5p inhibits the tumorigenesis of clear cell renal cell carcinoma by repressing UBE2T"],"prefix":"10.1007","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0087-9548","authenticated-orcid":false,"given":"Yucai","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cuijian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ding","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiming","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinqin","family":"Qian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weijie","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ninghan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanqing","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuesong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liqun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,2,7]]},"reference":[{"issue":"3","key":"661_CR1","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.eururo.2014.10.002","volume":"67","author":"A Znaor","year":"2015","unstructured":"Znaor A, Lortet-Tieulent J, Laversanne M, Jemal A, Bray F. International variations and trends in renal cell carcinoma incidence and mortality. Eur Urol. 2015;67(3):519\u201330.","journal-title":"Eur Urol"},{"issue":"1","key":"661_CR2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21551","volume":"69","author":"RL Siegel","year":"2019","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7\u201334.","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"661_CR3","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.eururo.2011.06.049","volume":"60","author":"B Ljungberg","year":"2011","unstructured":"Ljungberg B, Campbell SC, Choi HY, et al. The epidemiology of renal cell carcinoma. Eur Urol. 2011;60(4):615\u201321.","journal-title":"Eur Urol"},{"issue":"1","key":"661_CR4","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.eururo.2016.02.029","volume":"70","author":"H Moch","year":"2016","unstructured":"Moch H, Cubilla AL, Humphrey PA, Reuter VE, Ulbright TM. The 2016 WHO classification of tumours of the urinary system and male genital organs-part a: renal, penile, and testicular tumours. Eur Urol. 2016;70(1):93\u2013105.","journal-title":"Eur Urol"},{"issue":"5","key":"661_CR5","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.eururo.2015.01.005","volume":"67","author":"B Ljungberg","year":"2015","unstructured":"Ljungberg B, Bensalah K, Canfield S, et al. EAU guidelines on renal cell carcinoma: 2014 update. Eur Urol. 2015;67(5):913\u201324.","journal-title":"Eur Urol"},{"issue":"10","key":"661_CR6","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1101\/gr.093963.109","volume":"19","author":"G Markson","year":"2009","unstructured":"Markson G, Kiel C, Hyde R, et al. Analysis of the human E2 ubiquitin conjugating enzyme protein interaction network. Genome Res. 2009;19(10):1905\u201311.","journal-title":"Genome Res"},{"issue":"4","key":"661_CR7","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.molcel.2006.06.024","volume":"23","author":"YJ Machida","year":"2006","unstructured":"Machida YJ, Machida Y, Chen Y, et al. UBE2T is the E2 in the Fanconi anemia pathway and undergoes negative autoregulation. Mol Cell. 2006;23(4):589\u201396.","journal-title":"Mol Cell"},{"issue":"5","key":"661_CR8","doi-asserted-by":"publisher","first-page":"361","DOI":"10.3727\/096504016X14685034103310","volume":"24","author":"Y Wang","year":"2016","unstructured":"Wang Y, Leng H, Chen H, et al. Knockdown of UBE2T inhibits osteosarcoma cell proliferation, migration, and invasion by suppressing the PI3K\/Akt signaling pathway. Oncol Res. 2016;24(5):361\u20139.","journal-title":"Oncol Res"},{"key":"661_CR9","doi-asserted-by":"publisher","first-page":"8359","DOI":"10.2147\/CMAR.S202631","volume":"11","author":"LL Liu","year":"2019","unstructured":"Liu LL, Zhu JM, Yu XN, et al. UBE2T promotes proliferation via G2\/M checkpoint in hepatocellular carcinoma. Cancer Manag Res. 2019;11:8359\u201370.","journal-title":"Cancer Manag Res"},{"issue":"2","key":"661_CR10","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","volume":"116","author":"DP Bartel","year":"2004","unstructured":"Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116(2):281\u201397.","journal-title":"Cell"},{"issue":"1","key":"661_CR11","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12943-020-1132-x","volume":"19","author":"W Wang","year":"2020","unstructured":"Wang W, Hu W, Wang Y, et al. Long non-coding RNA UCA1 promotes malignant phenotypes of renal cancer cells by modulating the miR-182-5p\/DLL4 axis as a ceRNA. Mol Cancer. 2020;19(1):18.","journal-title":"Mol Cancer"},{"key":"661_CR12","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/1476-4598-13-109","volume":"13","author":"X Xu","year":"2014","unstructured":"Xu X, Wu J, Li S, et al. Downregulation of microRNA-182-5p contributes to renal cell carcinoma proliferation via activating the AKT\/FOXO3a signaling pathway. Mol Cancer. 2014;13:109.","journal-title":"Mol Cancer"},{"issue":"11","key":"661_CR13","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1158\/1541-7786.MCR-17-0762","volume":"16","author":"P Kulkarni","year":"2018","unstructured":"Kulkarni P, Dasgupta P, Bhat NS, et al. Elevated miR-182-5p associates with renal cancer cell mitotic arrest through diminished MALAT-1 expression. Mol Cancer Res. 2018;16(11):1750\u201360.","journal-title":"Mol Cancer Res"},{"issue":"W1","key":"661_CR14","doi-asserted-by":"publisher","first-page":"W98","DOI":"10.1093\/nar\/gkx247","volume":"45","author":"Z Tang","year":"2017","unstructured":"Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45(W1):W98-w102.","journal-title":"Nucleic Acids Res"},{"issue":"23","key":"661_CR15","doi-asserted-by":"publisher","first-page":"3251","DOI":"10.1093\/bioinformatics\/btm369","volume":"23","author":"A Subramanian","year":"2007","unstructured":"Subramanian A, Kuehn H, Gould J, Tamayo P, Mesirov JP. GSEA-P: a desktop application for gene set enrichment analysis. Bioinformatics. 2007;23(23):3251\u20133.","journal-title":"Bioinformatics"},{"issue":"Database Issue","key":"661_CR16","doi-asserted-by":"publisher","first-page":"D92","DOI":"10.1093\/nar\/gkt1248","volume":"42","author":"JH Li","year":"2014","unstructured":"Li JH, Liu S, Zhou H, Qu LH, Yang JH. starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res. 2014;42(Database Issue):D92\u20137.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"661_CR17","doi-asserted-by":"publisher","first-page":"D155","DOI":"10.1093\/nar\/gky1141","volume":"47","author":"A Kozomara","year":"2019","unstructured":"Kozomara A, Birgaoanu M, Griffiths-Jones S. miRBase: from microRNA sequences to function. Nucleic Acids Res. 2019;47(D1):D155\u201362.","journal-title":"Nucleic Acids Res"},{"key":"661_CR18","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.ebiom.2019.08.006","volume":"47","author":"J Wang","year":"2019","unstructured":"Wang J, Li X, Wu X, et al. Role of immune checkpoint inhibitor-based therapies for metastatic renal cell carcinoma in the first-line setting: a Bayesian network analysis. EBioMedicine. 2019;47:78\u201388.","journal-title":"EBioMedicine"},{"key":"661_CR19","doi-asserted-by":"publisher","first-page":"107579","DOI":"10.1016\/j.pharmthera.2020.107579","volume":"213","author":"GR Tundo","year":"2020","unstructured":"Tundo GR, Sbardella D, Santoro AM, et al. The proteasome as a druggable target with multiple therapeutic potentialities: cutting and non-cutting edges. Pharmacol Ther. 2020;213:107579.","journal-title":"Pharmacol Ther"},{"issue":"4","key":"661_CR20","doi-asserted-by":"publisher","first-page":"525","DOI":"10.4155\/fmc.11.187","volume":"4","author":"L Dalla Via","year":"2012","unstructured":"Dalla Via L, Nardon C, Fregona D. Targeting the ubiquitin-proteasome pathway with inorganic compounds to fight cancer: a challenge for the future. Future Med Chem. 2012;4(4):525\u201343.","journal-title":"Future Med Chem"},{"key":"661_CR21","doi-asserted-by":"publisher","first-page":"100663","DOI":"10.1016\/j.drup.2019.100663","volume":"48","author":"S Narayanan","year":"2020","unstructured":"Narayanan S, Cai CY, Assaraf YG, et al. Targeting the ubiquitin-proteasome pathway to overcome anti-cancer drug resistance. Drug Resist Update. 2020;48:100663.","journal-title":"Drug Resist Update"},{"issue":"2","key":"661_CR22","doi-asserted-by":"publisher","first-page":"246","DOI":"10.3390\/cancers11020246","volume":"11","author":"BL Sailo","year":"2019","unstructured":"Sailo BL, Banik K, Girisa S, et al. FBXW7 in cancer: what has been unraveled thus far? Cancers (Basel). 2019;11(2):246.","journal-title":"Cancers (Basel)."},{"key":"661_CR23","unstructured":"Yang H, Chen X, Li K et al (2019) Repurposing old drugs as new inhibitors of the ubiquitin-proteasome pathway for cancer treatment. Semin Cancer Biol"},{"issue":"22","key":"661_CR24","doi-asserted-by":"publisher","first-page":"8752","DOI":"10.1158\/0008-5472.CAN-09-1809","volume":"69","author":"T Ueki","year":"2009","unstructured":"Ueki T, Park JH, Nishidate T, et al. Ubiquitination and downregulation of BRCA1 by ubiquitin-conjugating enzyme E2T overexpression in human breast cancer cells. Cancer Res. 2009;69(22):8752\u201360.","journal-title":"Cancer Res"},{"issue":"6","key":"661_CR25","doi-asserted-by":"publisher","first-page":"4485","DOI":"10.3892\/ol.2016.5237","volume":"12","author":"YQ Gong","year":"2016","unstructured":"Gong YQ, Peng D, Ning XH, et al. UBE2T silencing suppresses proliferation and induces cell cycle arrest and apoptosis in bladder cancer cells. Oncol Lett. 2016;12(6):4485\u201392.","journal-title":"Oncol Lett"},{"key":"661_CR26","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.omtn.2019.04.013","volume":"16","author":"X Wei","year":"2019","unstructured":"Wei X, You X, Zhang J, Zhou C. MicroRNA-1305 inhibits the stemness of LCSCs and tumorigenesis by repressing the UBE2T-dependent Akt-signaling pathway. Mol Ther Nucleic Acids. 2019;16:721\u201332.","journal-title":"Mol Ther Nucleic Acids"},{"issue":"1","key":"661_CR27","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1186\/s13046-020-01734-4","volume":"39","author":"J Sun","year":"2020","unstructured":"Sun J, Zhu Z, Li W, et al. UBE2T-regulated H2AX monoubiquitination induces hepatocellular carcinoma radioresistance by facilitating CHK1 activation. J Exp Clin Cancer Res. 2020;39(1):222.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"661_CR28","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s12943-019-1089-9","volume":"18","author":"X Jing","year":"2019","unstructured":"Jing X, Yang F, Shao C, et al. Role of hypoxia in cancer therapy by regulating the tumor microenvironment. Mol Cancer. 2019;18(1):157.","journal-title":"Mol Cancer"},{"issue":"1","key":"661_CR29","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.radonc.2011.05.059","volume":"101","author":"CH Ramaekers","year":"2011","unstructured":"Ramaekers CH, van den Beucken T, Meng A, et al. Hypoxia disrupts the Fanconi anemia pathway and sensitizes cells to chemotherapy through regulation of UBE2T. Radiother Oncol. 2011;101(1):190\u20137.","journal-title":"Radiother Oncol"},{"issue":"43","key":"661_CR30","doi-asserted-by":"publisher","first-page":"6386","DOI":"10.3748\/wjg.v25.i43.6386","volume":"25","author":"J Guo","year":"2019","unstructured":"Guo J, Wang M, Wang JP, Wu CX. Ubiquitin-conjugating enzyme E2T knockdown suppresses hepatocellular tumorigenesis via inducing cell cycle arrest and apoptosis. World J Gastroenterol. 2019;25(43):6386\u2013403.","journal-title":"World J Gastroenterol"},{"issue":"3","key":"661_CR31","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/nrd.2016.246","volume":"16","author":"R Rupaimoole","year":"2017","unstructured":"Rupaimoole R, Slack FJ. MicroRNA therapeutics: towards a new era for the management of cancer and other diseases. Nat Rev Drug Discov. 2017;16(3):203\u201322.","journal-title":"Nat Rev Drug Discov"},{"key":"661_CR32","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.canlet.2020.04.021","volume":"488","author":"S Yan","year":"2020","unstructured":"Yan S, Wang H, Chen X, et al. MiR-182-5p inhibits colon cancer tumorigenesis, angiogenesis, and lymphangiogenesis by directly downregulating VEGF-C. Cancer Lett. 2020;488:18\u201326.","journal-title":"Cancer Lett"},{"key":"661_CR33","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/j.omtn.2020.10.010","volume":"22","author":"S Zhu","year":"2020","unstructured":"Zhu S, Liu Y, Wang X, Wang J, Xi G. lncRNA SNHG10 promotes the proliferation and invasion of osteosarcoma via Wnt\/\u03b2-catenin signaling. Mol Ther Nucleic Acids. 2020;22:957\u201370.","journal-title":"Mol Ther Nucleic Acids"},{"key":"661_CR34","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.canlet.2019.10.044","volume":"469","author":"C Seidl","year":"2020","unstructured":"Seidl C, Panzitt K, Bertsch A, et al. MicroRNA-182-5p regulates hedgehog signaling pathway and chemosensitivity of cisplatin-resistant lung adenocarcinoma cells via targeting GLI2. Cancer Lett. 2020;469:266\u201376.","journal-title":"Cancer Lett"},{"issue":"2","key":"661_CR35","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1261\/rna.034926.112","volume":"19","author":"K Krishnan","year":"2013","unstructured":"Krishnan K, Steptoe AL, Martin HC, et al. MicroRNA-182-5p targets a network of genes involved in DNA repair. RNA. 2013;19(2):230\u201342.","journal-title":"RNA"}],"container-title":["Human Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-021-00661-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13577-021-00661-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-021-00661-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,23]],"date-time":"2022-02-23T16:10:08Z","timestamp":1645632608000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13577-021-00661-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,7]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["661"],"URL":"https:\/\/doi.org\/10.1007\/s13577-021-00661-6","relation":{},"ISSN":["1749-0774"],"issn-type":[{"value":"1749-0774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,7]]},"assertion":[{"value":"6 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Medical Ethics Committee of Peking University First Hospital (Approval No. 2015[977]). All animal experiments were followed by the Guide for the Care and Use of Laboratory Animals and approved by the Ethical Committee of Peking University First Hospital.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}